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ABSTRACT
Understanding the role of differential gene expression in cancer
etiology and cellular process is a complex problem that continues
to pose a challenge due to sheer number of genes and inter-related
biological processes involved. In this paper, we employ an unsu-
pervised topic model, Latent Dirichlet Allocation (LDA) to mitigate
overfitting of high-dimensionality gene expression data and to fa-
cilitate understanding of the associated pathways. LDA has been
recently applied for clustering and exploring genomic data but not
for classification and prediction. Here, we proposed to use LDA in
clustering as well as in classification of cancer and healthy tissues
using lung cancer and breast cancer messenger RNA (mRNA) se-
quencing data. We describe our study in three phases: clustering,
classification, and gene interpretation. First, LDA is used as a clus-
tering algorithm to group the data in an unsupervised manner. Next
we developed a novel LDA-based classification approach to classify
unknown samples based on similarity of co-expression patterns.
Evaluation to assess the effectiveness of this approach shows that
LDA can achieve high accuracy compared to alternative approaches.
Lastly, we present a functional analysis of the genes identified using
a novel topic profile matrix formulation. This analysis identified
several genes and pathways that could potentially be involved in
differentiating tumor samples from normal. Overall, our results
project LDA as a promising approach for classification of tissue
types based on gene expression data in cancer studies.
KEYWORDS
Topic modeling, Latent Dirichlet Allocation, Clustering, Classifica-
tion, Machine learning, Cancer, Gene expression
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1 INTRODUCTION
Traditional diagnosis for cancer is based on clinical and morpholog-
ical data, but these methods have been reported to have limitations
in their diagnostic ability. [1, 12]. To overcome the limitations, can-
cer detection based on genomic data has been proposed [17, 18]. In
recent years, with the wide employment of microarray and next-
generation sequencing methods, increase in data volume poses both
promise and challenges to researchers in identifying patterns and
analyzing the data [15]. Although there has been a lot of research in
the identification of differentially expressed genes associated with
various types of cancer tissues, typically small sample size and high
dimensionality of expression data continues to pose challenges to
researchers. Understanding and interpretation of results remains a
key challenge in analyzing gene expression data.
Topicmodeling, amachine learning approach has shown promise
in the fields of text mining and image retrieval, where it has been
successfully implemented to extract information from high dimen-
sional data [6, 14, 24]. Latent Dirichlet Allocation (LDA) is one of
the most popular topic modeling approaches in text mining among
others like Latent Semantic Indexing (LSI) and Probabilistic Latent
Semantic Analysis (PLSA) [9, 11]. Since its emergence, researchers
have implemented this approach in biomedical text mining as well
[4, 25].
Given the successful implementation of topic models in discover-
ing the useful structure of the documents, researchers are beginning
to implement topic modeling approaches to analyze data other than
document collections [8, 27]. Recently, there have been efforts to use
topic modeling techniques in the field of bioinformatics to perform
unsupervised analysis and obtain insights into high-dimensional
-omics data [13, 16, 22, 23]. To gain better understanding into cancer
classification and gene identification from such data, in this paper,
we focus on the class prediction of breast cancer and lung cancer
based on gene expression data using topic modeling.
We approached this study in three phases (Figure 1). In the first
phase, we employed LDA as a clustering application. LDA has
been successfully applied as a clustering algorithm for gene expres-
sion data in the past [28]. Here, we confirmed that LDA-derived
document clusters based on our rank-based data transformation
technique show clear separation between cancer and healthy tissue
samples. In the second phase, we investigated the application of
LDA as a classification algorithm. This involved optimizing several
algorithmic parameters including the number of topics and algo-
rithm passes with respect to classification of gene expression data.
We used 10-fold cross validation to estimate classification effective-
ness. We compared our results with alternative machine learning
techniques including Support Vector Machine (SVM), Naive Bayes
and Random Forest classification, as well as Principal Component
Analysis (PCA) and Hierarchical Clustering for unsupervised learn-
ing. In the third phase, we additionally investigated the effectiveness
of LDA in identifying genes differentially regulated between cancer
and normal tissues. We explored the degree to which specific topics
identified by the LDA algorithm correspond to gene regulatory
pathways which vary between tumor and normal tissues.
The remaining of this paper is organized as follows. In Sec-
tion 2, we review the related work of implementing LDA in gene
expression data. In Section 3, we describe data collection and pre-
processing while in Section 4 we describe our proposed method,
evaluation techniques, results from two data sets and interpretation
of identified differentially expressed genes.
2 RELATEDWORK
One of the challenges in using LDA for genetic studies is the nature
of the data. The input of topic modeling is typically a simplified
bag-of-words representation of a corpus. However, gene expression
data is numerical in nature, and thus needs to be transformed into
text to provide appropriate input for the LDA algorithm. The most
commonly used transformation method is scaling the matrix and
interpreting the discrete values as gene/word occurrences. The
higher the expression value, the higher the frequency of the gene in
the bag of words [3, 19]. One limitation using this approach is genes
that have zero expression value will not be present in the training
corpus. Consequently, this transformation approach is suitable for
clustering and feature reduction, but not for classification because
the test set might have genes that are unseen by the trained model.
More recently, Zhao et al. [28] used a different transformation
method for generating a corpus. For each gene, expression values
were normalized to 0 (lower than median) or 1 (higher than me-
dian). The samples were then transformed into a bag-of-words,
containing only genes with normalized value 1. This transforma-
tion method does not capture the deviation between samples. That
is, two differentially expressed genes are treated the same regard-
less of the degree of deviation. Besides, this method is not feasible
for imbalanced dataset as the cutoff point between two different
classes could not be represented by median value. Rogers et al. [22]
used Latent Process Decomposition (LPD), a derivative of LDA, to
capture the continuous nature of gene expression data. No signifi-
cant difference in terms of accuracy has been reported using LPD
compared to classical approaches like pLSA [3].
To alleviate these limitations and broaden the range of appli-
cations using LDA, we propose a novel transformation strategy
to generate bag of words. We adapted the gene ranking method
from Wang et al. [26], which is described in detail in Section 3.2.
The rationale behind this ranking is that relative ordering of gene
expression is generally stable in a particular type of normal human
tissue but is widely disturbed in a diseased tissue. Ranking method
is able to capture the degree of deviation of gene expression across
different samples and still enable gene interpretability of topics
using topic profiles.
3 METHODS
3.1 Data Collection and Filtering
We obtained the mRNA-Seq data of 229 breast invasive carcinoma
samples and 98 lung squamous cell carcinoma samples from The
Cancer Genome Atlas (TCGA) data portal 1. We artificially balanced
the data using only the tumor samples with matched normals. Out
of 229 breast cancer samples, 117 represent primary solid tumor and
112 represent solid normal tissue. Of the 98 lung cancer samples,
half of the data (49) represent primary solid tumor and the other
half (49) represent solid tissue normal. Both datasets have 60483
variables with an abundance of zero values – roughly 45% of the
datasets. Genes that have zero expression value in more than 10%
of samples were removed. This filtering step might remove some
differentially expressed genes but such stringent threshold was used
to prevent any bias (multiple bins having genes with exclusively
zero expression value) that might arise in the preprocessing step.
After filtering, a total of 23424 genes remained in the breast cancer
data and 23996 genes remained in the lung cancer data.
3.2 Preprocessing
Here, we used a ranking approach to transform gene expression
values into a bag-of-words. Within each sample, genes were sorted
in ascending order based on their expression values. Expression
values form a distribution that is divided into 20 bins. The perfor-
mance of the algorithm is robust against the bin size (5, 10, 20, 30,
40 bins) and this is expected since the number of bins represents
the relative ranking of expression level instead of absolute ranking
(data not shown).
We chose 20 bins as a representative of the performed experi-
ments. Actual expression values were then replaced with a quan-
tized value (expression rank) based on its position. Value 1 indicates
the group with lowest expression level and value 20 indicates the
group with highest expression level. The combination of each gene
with its corresponding expression rank (separated by a hyphen),
generated a bag of words for each sample. For example, if gene
BRCA1 was found in quantized bin 3 for a particular sample, the
bag-of-words associated with that sample would include the word
BRAC1-3 to represent the ranked and quantized expression of this
gene. It is important to note that as a result of quantization, com-
parison between gene and word may not be absolute since one
gene might represent many words across the samples. To extract
gene-specific information from the LDA-derived model, it is thus
necessary to develop a technique to reverse this one-to-many map-
ping and trace back genes from the corresponding words without
deviating much from the expression rank (Section 4.2). After the
transformation, the breast cancer data corpus had 229 documents
and 23424 words within each document. The lung cancer data cor-
pus had 98 documents and each document contained 23996 words.
1https://portal.gdc.cancer.gov/
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Figure 1: Flowchart of the proposed approach. Highlighted
boxes represent the sequence of steps involved. Dashed lines
divide the analysis into four groups: Training, Clustering,
Classification and gene interpretation. Barplots represent
the topic distribution of samples.
4 RESULTS AND ANALYSIS
For each dataset, LDA was implemented using an open-source
Python library, Gensim [21]. The number of passes and number
of topics were set to 10 and 3 respectively. These parameters were
determined experimentally to provide the optimum performance
(data not shown). The LDA algorithm produces two matrices: the
topic-sample matrix, which expresses the computed probability
of topics in a particular sample (document), and the topic-word
matrix, containing the probability distribution over all available
words for each topic. The LDA-derived matrices were utilized to
perform analysis in 3 phases: clustering, classification and gene
interpretation.
4.1 Clustering
Average topic distributions of samples from each class (normal
and cancer) are depicted in Figure 2. This topic-sample matrix can
be used for feature extraction/projection in a manner analogous
to principal component analysis (PCA). Each column vector of
the topic-sample matrix represents a single sample. There is one
value in this vector for each topic, expressing the degree of asso-
ciation between the topic and the sample. Complete-linkage and
euclidean-distance-based Hierarchical Clustering was applied on
the topic-sample matrix to cluster the samples with similar proba-
bility distributions. The heatmap in Figure 2 shows that for both
breast cancer and lung cancer data, samples were clearly grouped
together into two classes, cancer and normal. Colors from red to
green in the heatmap represent topic probabilities of the samples,
ranging from 0 to 1.
The clustering result from LDA was compared with other con-
ventional clustering and projection methods including hierarchical
clustering and PCA. Hierarchical clustering was directly applied to
(a)
(b)
Figure 2: Topic probability distribution and Hierarchical
clustering of samples using derived topic probability for (a)
breast carcinoma and (b) lung squamous cell carcinoma. Bar
plots represent average topic-sample probability for the 3
topics. Heat map shows the clustering of samples into two
classes.
the raw expression values for breast cancer (23424 genes) and lung
cancer (23996 genes). PCA was first used to transform the original
data into components that retain 90% of the variance. Hierarchi-
cal clustering was then applied on the transformed data. For both
datasets, cluster purity and number of misclassified samples were
calculated using Equation 1 to evaluate the clustering performance.
Purity = 1/N
k∑
i=0
max j |ci ∩ tj | (1)
Where N = number of data points, k = number of clusters, ci=
a cluster in K, tj = classification that has the maximum count for
cluster ci .
Table 1 shows the clustering results of the three methods where
the number of clusters (K) is fixed at 2, 3, and 4 clusters. Overall,
LDA clusters align more closely to known cancer/healthy tissue
labels than those obtained by PCA and Hierarchical Clustering. One
advantage of LDA-based clustering for gene expression data may be
its mutually non-exclusive assumption. Most non-fuzzy clustering
approaches have a mutually exclusive/independence assumption
that a sample/gene is restricted to only one cluster. This assump-
tion might not be logical for gene expression data largely when
a sample/gene share characteristics with more than one cluster
(that is one gene can be involved in different pathways). Thus using
LDA for clustering of gene data would reflect the complex interplay
between genes and pathways and improve quality of the results.
Table 1: Clustering results of LDA-derived topic probabilities, PCA reduced features, and Hierarchical Clustering.
Method K Breast cancer Lung cancerNo. of Misclassified Samples Cluster Purity No. of Misclassified Samples Cluster Purity
Latent Dirichlet Allocation (LDA)
2 11 0.952 1 0.990
3 11 0.952 1 0.990
4 11 0.952 1 0.990
PCA
2 112 0.512 43 0.561
3 112 0.512 43 0.561
4 109 0.524 43 0.561
Hierarchical Clustering
2 112 0.511 48 0.510
3 112 0.511 19 0.806
4 112 0.511 15 0.847
4.2 Classification
In this section, we propose a novel approach to classification using
LDA-based topic modeling, and explore the effectiveness of the
proposed method in distinguishing gene expression patterns in
breast and lung cancer tissues from those in healthy tissue. In
contrast to the work by [3] where LDA is solely used as a feature
extraction method and requires running LDA on both training and
testing data, the approach proposed here applies the LDA algorithm
only to the training data.
First, training of the LDA algorithm proceeds in the samemanner
as described previously for LDA-based clustering. For testing, LDA-
derived topic-sample and topic-word matrices from the trained
model are employed. To revert/collapse the genes from their cor-
responding words, expression rank and probabilities of all words
representing a gene are taken and normalized over the entire prob-
ability distribution (Equation 2):
expд =
∑j
j=1 rank
j
д × prob
j
д∑j
j=1 prob
j
д
(2)
where expд represents the collapsed expression rank of a gene д,
j is the total number of words that representing gene д. rankд ∈
(rank1д , rank2д , ..., rank
j
д ) is a vector of rank extracted from words
and probд ∈ (prob1д , prob2д , ..., prob
j
д ) is the vector of corresponding
probabilities for the words.
Combining the topic-word probabilities in this manner results
in a new topic-gene matrix, in which each topic is associated with
a specific rank value for each gene. The resulting topic profile
facilitates subsequent classification.
To classify a test sample based on the trained LDA, we need to
determine topic probability distribution of the test sample. First,
the same pre-processing step described for clustering is applied
to the test data, resulting in a bag-of-words based on ranked gene
expression for each test sample. Then similarity (MSE) between
testing data and each topic profile was calculated using Equation 3.
The lower the MSE, the more similar the topic.
MSE =
д∑
д=1
(expд − binд)2 (3)
Where expд represents the collapsed expression rank of geneд in
a topic profile and binд represents expression rank of gene д in test
sample. Gaussian normalization was performed to reduce the range
of the MSE, thus avoiding overflow errors in computation, without
affecting the variation between topics and the softmax function
(Equation 4) is applied to ensure that the probability distribution
properly sums to 1.0 [5]. The probability distribution determined
from similarity is used for prediction.
So f tmaxOutput =
esMSE∑k
k=1 e
sMSE
(4)
The performance of our classification approach was compared
with popular supervised methods including SVM, Naive Bayes
and Random Forest classifiers using 10-fold cross validation. Tradi-
tional metrics for comparison like accuracy, precision, recall and
F-measure were applied. As shown in Table 2, LDA achieves a
competitive performance comparable to other algorithms.
4.3 Gene Interpretation
We utilized topic profiles from the two data sets to perform pathway
analysis and disease annotation of differentially expressed genes
within each topic. A list of differentially expressed genes (DEGs) is
extracted by computing the difference in expression rank of each
topic with a baseline. For the experiments shown here, topic 3
was chosen as the baseline in both breast cancer and lung cancer
datasets, since it shows the highest probability in normal samples
(Figure 2). DEGs were then identified from all other topics (1 and
2 in this case). A threshold rank-difference of 5 was used to ex-
tract the significant genes and also limit the number of genes for
further analysis. Thus, the extracted genes have at least 5 ranking
changes between normal and tumor that could potentially represent
significant dysregulation in our analysis.
We examined the pathway enrichment of the differentially ex-
pressed genes using DAVID Bioinformatics Resources 6.8 2 [10]
to explore the KEGG pathway database. Figures 3 and 4 show the
number of genes and statistically enriched pathways in the topics
for breast cancer and lung cancer, respectively.
The relevance of the identified differentially expressed genes
was validated using the DAVID bioinformatics suite [10] and the
2https://david.ncifcrf.gov/home.jsp
Table 2: Classification results of our proposed approach and three supervised algorithms: SVM, Naive Bayes, and Random
Forest.
Breast cancer Lung cancer
F-measure Accuracy Specificity Sensitivity F-measure Accuracy Specificity Sensitivity
LDA 0.991 0.991 1.000 0.983 LDA 0.990 0.990 1.000 0.980
SVM 0.970 0.978 0.973 0.966 SVM 0.969 0.969 0.980 0.959
Naive Bayes 0.974 0.974 1.000 0.945 Naive Bayes 0.980 0.980 0.980 0.980
Random Forest 0.987 0.987 0.991 0.983 Random Forest 0.990 0.990 1.000 0.980
Functional pathways Adj. p-value
ECM-receptor interaction 0.0191
Cytokine-cytokine receptor interaction 0.0223
Cell cycle 0.0305
Oocyte meiosis 0.0336
Alcoholism 0.0369
PPAR signaling pathway 0.0455
Focal adhesion 0.0811
PI3K-Akt signaling pathway 0.0865
Adipocytokine signaling pathway 0.1090
Malaria 0.1146
AMPK signaling pathway 0.1334
Progesterone-mediated oocyte maturation 0.2349
Drug metabolism - cytochrome P450 0.2767
Metabolism of xenobiotics by cytochrome P450 0.3410
Systemic lupus erythematosus 0.3994
Regulation of lipolysis in adipocytes 0.4030
Rap1 signaling pathway 0.5075
p53 signaling pathway 0.5305
Amphetamine addiction 0.5336
Ras signaling pathway 0.5479
Mineral absorption 0.5537
Melanoma 0.5566
ABC transporters 0.5653
Functional pathways Adj. p-value
Cell adhesion molecules (CAMs) 0.3136
Tight junction 0.7973
Functional pathways Adj. p-value
Phenylalanine metabolism 0.7487
Biosynthesis of antibiotics 0.7880
T1DEG T2DEG
Figure 3: Functional annotation of dysregulated genes in
breast cancer. Venn diagram of differentially expressed
genes in Topic 1, in Topic 2 for breast cancer. Tables rep-
resent the affected pathways for each subset of genes, and
their adjusted p-value. The lower the adjusted p-value, the
higher the significance of pathway.
NIH genetic association database (GAD) [2]. The DEGs were ex-
tracted by comparing the expression profile for normal and tumor
samples. For each gene, its expression rank (expд ) in topic profile
matrix (∼24000×3) was multiplied with respective topic probability
distribution of normal group (3×1) and tumor group (3×1). This
would generate two expression profiles: one for normal samples
(∼24000×1) and one for tumor samples (∼24000×1). The difference
in expression rank between these two profiles was computed. Top
250 DEGs was extracted both for breast cancer and lung cancer and
annotated using DAVID Bioinformatics Resources 6.8 in terms of
GAD disease. Table 3 shows the top 5 highly related diseases which
are ranked ascendingly according to their adjusted p-value.
As expected, for the gene list extracted from breast cancer data
corpus, ‘breast cancer’ is the disease with highest enrichment (low-
est adjusted p-value) and for lung cancer data corpus, ’smoking
cessation’ and ’chronic obstructive pulmonary disease’ are highly
enriched.
Functional pathways Adj. p-value
Cell cycle 2.63E-07
Oocyte meiosis 0.0080
Progesterone-mediated oocyte maturation 0.0196
p53 signaling pathway 0.0634
Protein digestion and absorption 0.2188
Dilated cardiomyopathy 0.4506
Malaria 0.5602
Adrenergic signaling in cardiomyocytes 0.5689
Hypertrophic cardiomyopathy (HCM) 0.6299
PI3K-Akt signaling pathway 0.6365
Ras signaling pathway 0.6462
ECM-receptor interaction 0.6690
ABC transporters 0.7284
PPAR signaling pathway 0.7372
Bile secretion 0.7416
T2DEGT1DEG
Functional pathways Adj. p-value
Complement and coagulation cascades 0.8267
Cell adhesion molecules (CAMs) 0.8383
Amoebiasis 0.8740
Malaria 0.9190
Fanconi anemia pathway 0.9305
Drug metabolism - cytochrome P450 0.9623
Functional pathways Adj. p-value
Basal cell carcinoma 0.0048
Pathways in cancer 0.1110
Hippo signaling pathway 0.2497
Signaling pathways regulating pluripotency of 
stem cells
0.2987
Figure 4: Functional annotation of dysregulated genes in
lung cancer. Venn diagram of differentially expressed genes
in Topic 1, in Topic 2 for Lung Cancer. Tables represent the
affected pathways for each subset of genes, and their ad-
justed p-value. The lower the adjusted p-value, the higher
the significance of the pathway.
Table 3: Top 5 annotated diseases, arranged in ascending or-
der of adjusted p-value, from breast and lung cancer DEGs.
Breast Cancer Adj. p-value Lung Cancer
Adj. p-
value
Breast cancer 2.7E-2 Cleft lip, cleft palate 3.7E-1
Alzheimer’s
disease 1.7E-1 Smoking cessation 4.0E-1
Chorioamnionitis 2.4E-1 Chronic obstructive pul-monary disease 9.2E-1
Colorectal cancer 3.6E-1 Breast cancer 9.5E-1
Lung cancer 4.3E-1 Leukemia, lymphocytic,chronic, B-cell 9.5E-1
5 DISCUSSION
Many approaches to diagnostic classification based on mRNA ex-
pression focus primarily on differential expression. The LDA-based
approach described here differs in that the focus is primarily on
co-expression. Just as textual LDA attempts to group co-occurring
words into topics in order to explain the topic composition of a doc-
ument, gene expression LDA can be used to identify co-regulated
groups of genes that together explain the overall patterns of gene
expression in healthy and disease states. In an unsupervised mode,
this technique has shown a somewhat surprising ability to produce
gene-collections (topics) that differ significantly between cancer
and healthy tissues. Augmenting this technique with class labels
results in an even more capable diagnostic classifier.
Here, our approach is only tested on gene expression data from
next generation sequencing. Nevertheless, we expect it to work
equally with similar data from different platforms or for different
tasks such as disease subtype classification [7], survival analysis
and treatment prognosis prediction [20]. We have shown that by
using only gene expression data, the model was able to cluster
the data into topics that are biologically coherent and meaningful.
An interesting next step would be to include additional lifestyle
and clinical metadata in the bag-of-words representing each sam-
ple. For example, by tagging clinical study data with labels such
as smoker/non-smoker, male/female, adult/child, etc., associations
between subject groups corresponding to these labels, disease state,
and gene expression might further be identified. Understanding as-
sociated pathways and genomic etiology in these tasks is important
in stratifying patients according to their risk and provide better
diagnosis.
6 CONCLUSION
Overall our approach provides a novel direction for applying the
LDA algorithm to identify and group differentially expressed genes
between healthy and cancer tissues of various types. A novel tech-
nique for transformation of gene expression levels to words is
presented and shown to be effective. Comparative evaluation of
this approach with state-of-the-art pattern classification methods
confirms the effectiveness of the proposed methodology. Differ-
ential gene expression patterns associated with lung and breast
cancer were identified and validated as relevant using pathway
analysis and the NIH’s genetic association database. Next steps
include testing the effectiveness of this LDA-based classification
approach on genetic and epigenetic variation patterns and also
testing the effectiveness of LDA as a supervised algorithm for the
more complex problem of distinguishing among cancer subtypes.
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